Correlation Between Franklin Genomic and Goldman Sachs
Can any of the company-specific risk be diversified away by investing in both Franklin Genomic and Goldman Sachs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Genomic and Goldman Sachs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Franklin Genomic Advancements and Goldman Sachs Future, you can compare the effects of market volatilities on Franklin Genomic and Goldman Sachs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Genomic with a short position of Goldman Sachs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Genomic and Goldman Sachs.
Diversification Opportunities for Franklin Genomic and Goldman Sachs
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Franklin and Goldman is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Genomic Advancements and Goldman Sachs Future in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goldman Sachs Future and Franklin Genomic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Genomic Advancements are associated (or correlated) with Goldman Sachs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goldman Sachs Future has no effect on the direction of Franklin Genomic i.e., Franklin Genomic and Goldman Sachs go up and down completely randomly.
Pair Corralation between Franklin Genomic and Goldman Sachs
Given the investment horizon of 90 days Franklin Genomic Advancements is expected to under-perform the Goldman Sachs. In addition to that, Franklin Genomic is 2.88 times more volatile than Goldman Sachs Future. It trades about -0.05 of its total potential returns per unit of risk. Goldman Sachs Future is currently generating about 0.38 per unit of volatility. If you would invest 3,545 in Goldman Sachs Future on September 12, 2024 and sell it today you would earn a total of 170.38 from holding Goldman Sachs Future or generate 4.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Franklin Genomic Advancements vs. Goldman Sachs Future
Performance |
| Timeline |
| Franklin Genomic Adv |
| Goldman Sachs Future |
Franklin Genomic and Goldman Sachs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Franklin Genomic and Goldman Sachs
The main advantage of trading using opposite Franklin Genomic and Goldman Sachs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Genomic position performs unexpectedly, Goldman Sachs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goldman Sachs will offset losses from the drop in Goldman Sachs' long position.| Franklin Genomic vs. Invesco DWA Industrials | Franklin Genomic vs. Invesco DWA Consumer | Franklin Genomic vs. Invesco DWA Consumer | Franklin Genomic vs. Invesco DWA Basic |
| Goldman Sachs vs. Goldman Sachs ETF | Goldman Sachs vs. Goldman Sachs Future | Goldman Sachs vs. Goldman Sachs Future | Goldman Sachs vs. Goldman Sachs Innovate |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |